Timothy Callaghan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Timothy Callaghan has a total of 477 co-authors. Here are the top co-authors by number of shared publications:
- Matt Motta
Department of Health Law, Policy, & Management, Boston University School of Public Health, Boston, MA, USA
20 shared publications Alva O. Ferdinand
Texas A&M University
6 shared publications- Kristin Lunz Trujillo
Boston College
6 shared publications Jennifer Ross
5 shared publications- Steven Sylvester
Utah Valley University
5 shared publications David Vincent Yokum
4 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
Pandemic Era Expansion of State Laws Governing the Professionalization of Community Health Workers
Introduction: Community Health Workers (CHWs) are trusted public health workers who strengthen healthcare access, quality, and cultural responsiveness by addressing social determinants of health. While CHW services show value, professionalization policies, including certification and training requirements, remain debated. Methods: To understand these policies, we conducted an empirical legal mapping study of CHW professionalism laws in 54 U.S. jurisdictions (50 states, DC, Puerto Rico, US Virgin Islands, and Guam) in effect in 2019 and 2024 following consensus legal mapping guidelines for legal research, coding, and quality control. Results: We screened 2,248 relevant laws, with 31 jurisdictions modifying CHW professionalization laws. Between 2019 and 2024, the number of jurisdictions with consistent terminology (16 to 21), defined CHW roles (15 to 21), laws concerning certification (14 to 22), and laws requiring training for practice or certification (21 to 23) increased. Jurisdictions with formal education requirements declined (12 to 8), while jurisdictions requiring training programs increased (12 to 20). Conclusion: CHW professionalization requires careful navigation. While increased professionalism might enhance workforce stability, it risks creating barriers to entry and undermining CHWs’ community-rooted identity. Future research is needed to identify the balance between CHW professionalism and the preservation of CHW status as trusted members of the communities they serve.
- 20 August 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
Open AccessPandemic Era Expansion of State Laws Governing the Professionalization of Community Health Workers
Introduction: Community Health Workers (CHWs) are trusted public health workers who strengthen healthcare access, quality, and cultural responsiveness by addressing social determinants of health. While CHW services show value, professionalization policies, including certification and training requirements, remain debated. Methods: To understand these policies, we conducted an empirical legal mapping study of CHW professionalism laws in 54 U.S. jurisdictions (50 states, DC, Puerto Rico, US Virgin Islands, and Guam) in effect in 2019 and 2024 following consensus legal mapping guidelines for legal research, coding, and quality control. Results: We screened 2,248 relevant laws, with 31 jurisdictions modifying CHW professionalization laws. Between 2019 and 2024, the number of jurisdictions with consistent terminology (16 to 21), defined CHW roles (15 to 21), laws concerning certification (14 to 22), and laws requiring training for practice or certification (21 to 23) increased. Jurisdictions with formal education requirements declined (12 to 8), while jurisdictions requiring training programs increased (12 to 20). Conclusion: CHW professionalization requires careful navigation. While increased professionalism might enhance workforce stability, it risks creating barriers to entry and undermining CHWs’ community-rooted identity. Future research is needed to identify the balance between CHW professionalism and the preservation of CHW status as trusted members of the communities they serve.
- Open Access
Temporal Changes in Immunization Information Systems Across U.S. States and Jurisdictions, 2000-2024
Background: Statewide immunization data are essential for monitoring vaccination trends and evaluating immunization program impact. In the United States, Immunization Information Systems (IIS) were established in the early 1990s to collect these data; however, operational, legal, and procedural details vary across states and over time. This study summarized differences in IIS characteristics, such as legal requirements and reporting procedures, across U.S. states and jurisdictions over time. Methods: We analyzed survey data from previous work in 2000 and the Centers for Disease Control and Prevention (CDC) in 2012, 2018, and 2024. Our review focused on legislation and reporting requirements for immunization registries across 50 states and 14 jurisdictions, including U.S. territories and Freely Associated States. Results: Between 2000 and 2024, legal frameworks and reporting practices for immunization registries expanded across U.S. states and jurisdictions. The number of states with laws or administrative rules authorizing immunization registries increased from 24 states in 2000 to all 50 states, the District of Columbia, five metropolitan areas, five U.S. territories, and three Freely Associated States in 2024. Over the same period, reporting requirements also became more widespread. The number of states and jurisdictions mandating providers to report immunization records increased from 12 in 2000 to 54 in 2024. Consent policies also changed over time. By 2024, most states and jurisdictions had adopted implicit consent for reporting children’s immunization records (41; 64%), while a smaller proportion required explicit parental consent (7; 11%) or implemented mandatory reporting without consent (14; 22%). Discussion: IIS infrastructure and reporting requirements have expanded across U.S. states and jurisdictions over the past two decades, while heterogeneity in consent policies and reporting practices persists. These temporal changes may need to be considered when interpreting IIS data, particularly in longitudinal and cross-jurisdictional analyses.
Open AccessTemporal Changes in Immunization Information Systems Across U.S. States and Jurisdictions, 2000-2024
Background: Statewide immunization data are essential for monitoring vaccination trends and evaluating immunization program impact. In the United States, Immunization Information Systems (IIS) were established in the early 1990s to collect these data; however, operational, legal, and procedural details vary across states and over time. This study summarized differences in IIS characteristics, such as legal requirements and reporting procedures, across U.S. states and jurisdictions over time. Methods: We analyzed survey data from previous work in 2000 and the Centers for Disease Control and Prevention (CDC) in 2012, 2018, and 2024. Our review focused on legislation and reporting requirements for immunization registries across 50 states and 14 jurisdictions, including U.S. territories and Freely Associated States. Results: Between 2000 and 2024, legal frameworks and reporting practices for immunization registries expanded across U.S. states and jurisdictions. The number of states with laws or administrative rules authorizing immunization registries increased from 24 states in 2000 to all 50 states, the District of Columbia, five metropolitan areas, five U.S. territories, and three Freely Associated States in 2024. Over the same period, reporting requirements also became more widespread. The number of states and jurisdictions mandating providers to report immunization records increased from 12 in 2000 to 54 in 2024. Consent policies also changed over time. By 2024, most states and jurisdictions had adopted implicit consent for reporting children’s immunization records (41; 64%), while a smaller proportion required explicit parental consent (7; 11%) or implemented mandatory reporting without consent (14; 22%). Discussion: IIS infrastructure and reporting requirements have expanded across U.S. states and jurisdictions over the past two decades, while heterogeneity in consent policies and reporting practices persists. These temporal changes may need to be considered when interpreting IIS data, particularly in longitudinal and cross-jurisdictional analyses.
- Open Access
- 19 May 2026
- Published by Center for Open Science in SocArXiv
The Public Health Impact of GLP-1 Advertising Exposure in the U.S.
The recent discovery that a class of drugs collectively known as “GLP-1s” (Glucagon-Like Peptide-1) can promote weight loss has led to a surge in pharmaceutical production, demand, and advertising. While previous research has considered the impact that advertising exposure may have on public demand for using GLP-1s for weight management, few have considered the broader public health impacts (both positive and negative) of GLP-1 advertising. For example, increased GLP-1 advertisement exposure could make people more self-conscious about their own weight and physical appearance. It could also promote destigmatizing views toward those who use GLP-1 products for weight management. In a nationally representative survey of N = 1,000 US adults, we find that people exposed to higher levels of GLP-1 advertising tend to hold more negative views about their own weight and physical appearance. We find no evidence that ad exposure is associated with destigmatizing views about those who use GLP-1 products, although we find strong evidence that exposure can stimulate demand for GLP-1 products. These results hold across a wide range of measures and model specifications. We conclude by discussing the potential public health risks of GLP-1 advertising, in a changing regulatory landscape.
- 19 May 2026
- Published by Center for Open Science in SocArXiv
Open AccessThe Public Health Impact of GLP-1 Advertising Exposure in the U.S.
The recent discovery that a class of drugs collectively known as “GLP-1s” (Glucagon-Like Peptide-1) can promote weight loss has led to a surge in pharmaceutical production, demand, and advertising. While previous research has considered the impact that advertising exposure may have on public demand for using GLP-1s for weight management, few have considered the broader public health impacts (both positive and negative) of GLP-1 advertising. For example, increased GLP-1 advertisement exposure could make people more self-conscious about their own weight and physical appearance. It could also promote destigmatizing views toward those who use GLP-1 products for weight management. In a nationally representative survey of N = 1,000 US adults, we find that people exposed to higher levels of GLP-1 advertising tend to hold more negative views about their own weight and physical appearance. We find no evidence that ad exposure is associated with destigmatizing views about those who use GLP-1 products, although we find strong evidence that exposure can stimulate demand for GLP-1 products. These results hold across a wide range of measures and model specifications. We conclude by discussing the potential public health risks of GLP-1 advertising, in a changing regulatory landscape.
- Open Access
- 11 November 2025
- Published by Center for Open Science in SocArXiv
Quantifying the Rise in Anti-Vaccine Policymaking Across State Legislatures Through the State Vaccine Policy Project (SVPP).
Since the onset of the COVID-19 pandemic, lawmakers across the US have introduced legislation aimed at weakening existing vaccine-related policies (e.g., vaccine mandates in employment or educational settings). However, reports of anti-vaccine policymaking (AVP) across state legislatures have been largely anecdotal. We offer a first-of-its-kind effort to quantify and standardize reporting of the prevalence, characteristics, and correlates of AVP by introducing the State Vaccine Policy Project (SVPP) database; a content-coded record of every piece of vaccine-related legislation introduced across all US state houses from 2019 - 2023. SVPP data reveal that both the total volume and proportion of anti-vaccine bills introduced across state legislatures has been increasing steadily since the onset of the COVID-19 pandemic, with nearly 1 in 10 anti-vaccine bills signed into law during that period. We also show that the rise in anti-vaccine legislating is attributable primarily to the legislative actions of state lawmakers affiliated with the Republican party, and that dozens of anti-vaccine bills directly aim to reduce the scope of vaccine mandates. In addition to offering a standardized and exhaustive assessment of the growth of anti-vaccine policy making across US state legislatures, our work provides scholars with a unique dataset for studying changes in the vaccine policy environment.
- 11 November 2025
- Published by Center for Open Science in SocArXiv
Open AccessQuantifying the Rise in Anti-Vaccine Policymaking Across State Legislatures Through the State Vaccine Policy Project (SVPP).
Since the onset of the COVID-19 pandemic, lawmakers across the US have introduced legislation aimed at weakening existing vaccine-related policies (e.g., vaccine mandates in employment or educational settings). However, reports of anti-vaccine policymaking (AVP) across state legislatures have been largely anecdotal. We offer a first-of-its-kind effort to quantify and standardize reporting of the prevalence, characteristics, and correlates of AVP by introducing the State Vaccine Policy Project (SVPP) database; a content-coded record of every piece of vaccine-related legislation introduced across all US state houses from 2019 - 2023. SVPP data reveal that both the total volume and proportion of anti-vaccine bills introduced across state legislatures has been increasing steadily since the onset of the COVID-19 pandemic, with nearly 1 in 10 anti-vaccine bills signed into law during that period. We also show that the rise in anti-vaccine legislating is attributable primarily to the legislative actions of state lawmakers affiliated with the Republican party, and that dozens of anti-vaccine bills directly aim to reduce the scope of vaccine mandates. In addition to offering a standardized and exhaustive assessment of the growth of anti-vaccine policy making across US state legislatures, our work provides scholars with a unique dataset for studying changes in the vaccine policy environment.
- Open Access
- 1 September 2025
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 28 (1) , 9-22
U.S. Public Opinion About Immigration Enforcement in Sensitive Locations
In 2011, the Director of U.S. Immigration and Customs Enforcement (ICE) issued a memorandum titled, “Enforcement Actions at or Focused on Sensitive Locations.” The memorandum stated that immigration enforcement actions should not occur at specified sensitive locations, which included schools, healthcare facilities, places of worship, sites of public religious ceremony, and sites of public demonstration. These policies were rescinded in January 2025, creating the possibility of enforcement actions in these locations. The aim of this study was to investigate U.S. public opinion regarding immigration enforcement in sensitive locations. We conducted an online survey of 3,563 American adults with quotas implemented on gender, age, race, and geographic location. The survey ran from January 23 to February 3, 2025. 3,563 individuals completed the survey. Age and political identification were the most consistent predictors of support for rescinding sensitive locations policy, as well as in the belief that such enforcement would not deter care seeking. Sympathy towards immigrants was also a predictor of support for sensitive locations policy. Our findings suggest that the majority of Americans do not think that ICE’s sensitive locations policy should be rescinded and believe that rescinding this policy will deter undocumented immigrants from seeking needed medical care for themselves and their children. A lack of support for rescinding this policy suggests that it should be reinstated, a move that would help to protect healthcare access for undocumented people and their families.
- 1 September 2025
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 28 (1) , 9-22
Open AccessU.S. Public Opinion About Immigration Enforcement in Sensitive Locations
In 2011, the Director of U.S. Immigration and Customs Enforcement (ICE) issued a memorandum titled, “Enforcement Actions at or Focused on Sensitive Locations.” The memorandum stated that immigration enforcement actions should not occur at specified sensitive locations, which included schools, healthcare facilities, places of worship, sites of public religious ceremony, and sites of public demonstration. These policies were rescinded in January 2025, creating the possibility of enforcement actions in these locations. The aim of this study was to investigate U.S. public opinion regarding immigration enforcement in sensitive locations. We conducted an online survey of 3,563 American adults with quotas implemented on gender, age, race, and geographic location. The survey ran from January 23 to February 3, 2025. 3,563 individuals completed the survey. Age and political identification were the most consistent predictors of support for rescinding sensitive locations policy, as well as in the belief that such enforcement would not deter care seeking. Sympathy towards immigrants was also a predictor of support for sensitive locations policy. Our findings suggest that the majority of Americans do not think that ICE’s sensitive locations policy should be rescinded and believe that rescinding this policy will deter undocumented immigrants from seeking needed medical care for themselves and their children. A lack of support for rescinding this policy suggests that it should be reinstated, a move that would help to protect healthcare access for undocumented people and their families.
- Open Access
- 27 August 2025
- Published by Center for Open Science in OSF Preprints
Public communication about science in 68 countries: Global evidence on how people encounter and engage with information about science
This 68-country survey (n = 71,922) examines science information diets and communication behavior, identifies cross-country differences, and tests how economic and sociopolitical conditions predict such differences. We find that social media are the most used sources of science information in most countries, except those with democratic-corporatist media systems where news media tend to be used more widely. People in collectivist societies are less outspoken about science in daily life, whereas lower education is associated with higher outspokenness. Limited access to digital media is correlated with participation in public protests on science matters. We discuss implications for future research, policy, and practice.
- 27 August 2025
- Published by Center for Open Science in OSF Preprints
Open AccessPublic communication about science in 68 countries: Global evidence on how people encounter and engage with information about science
This 68-country survey (n = 71,922) examines science information diets and communication behavior, identifies cross-country differences, and tests how economic and sociopolitical conditions predict such differences. We find that social media are the most used sources of science information in most countries, except those with democratic-corporatist media systems where news media tend to be used more widely. People in collectivist societies are less outspoken about science in daily life, whereas lower education is associated with higher outspokenness. Limited access to digital media is correlated with participation in public protests on science matters. We discuss implications for future research, policy, and practice.
- Open Access
- 30 July 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (11) , 3364-3372
Application of the actor-partner interdependence model to understand COVID-19 vaccine decision-making among US adolescents and their parents
Although adolescents play an important role in their medical decisions, including vaccination, few studies have considered their perceptions or role in vaccine decision-making. We apply the Actor-Partner Interdependence Model to understand actor (adolescent) and partner (parent) influences of vaccine hesitancy on the decision to vaccinate adolescents. We conducted a nationally representative survey of adolescents aged 12-17 years old and their parents (n = 721 dyads). Parents and adolescents completed separate online surveys measuring their vaccine hesitancy and intent to receive future doses of COVID-19 vaccine. We used structural equation modeling to estimate the association between vaccine hesitancy and adolescent vaccination among actors and partners using odds ratios (ORs) with 95% CIs. We identified a couple-oriented pattern in COVID-19 vaccine decision-making, with significant “actor effects” and “partner effects” on adolescent vaccination. Each unit increase in adolescent vaccine hesitancy was associated with 14% lower odds of adolescent vaccination (OR 0.86 [95% CI, 0.82-0.91]). For each unit increase in vaccine hesitancy among parents, the odds of adolescent vaccination decreased by 6% (OR 0.94 [95% CI, 0.91-0.98]). These findings suggest that vaccine promotion efforts should address vaccine hesitancy in adolescents in addition to their parents.
- 30 July 2025
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 194 (11) , 3364-3372
Open AccessApplication of the actor-partner interdependence model to understand COVID-19 vaccine decision-making among US adolescents and their parents
Although adolescents play an important role in their medical decisions, including vaccination, few studies have considered their perceptions or role in vaccine decision-making. We apply the Actor-Partner Interdependence Model to understand actor (adolescent) and partner (parent) influences of vaccine hesitancy on the decision to vaccinate adolescents. We conducted a nationally representative survey of adolescents aged 12-17 years old and their parents (n = 721 dyads). Parents and adolescents completed separate online surveys measuring their vaccine hesitancy and intent to receive future doses of COVID-19 vaccine. We used structural equation modeling to estimate the association between vaccine hesitancy and adolescent vaccination among actors and partners using odds ratios (ORs) with 95% CIs. We identified a couple-oriented pattern in COVID-19 vaccine decision-making, with significant “actor effects” and “partner effects” on adolescent vaccination. Each unit increase in adolescent vaccine hesitancy was associated with 14% lower odds of adolescent vaccination (OR 0.86 [95% CI, 0.82-0.91]). For each unit increase in vaccine hesitancy among parents, the odds of adolescent vaccination decreased by 6% (OR 0.94 [95% CI, 0.91-0.98]). These findings suggest that vaccine promotion efforts should address vaccine hesitancy in adolescents in addition to their parents.
- 3 June 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (11) , 1126-1133
Intention to Use RSVpreF Vaccine or Nirsevimab to Prevent Infant RSV Among Pregnant Individuals
Background: Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the United States. While 2 new immunization products have been developed to prevent RSV in infants—RSVpreF vaccine (a prefusion F protein-based vaccine for pregnant individuals) and nirsevimab (a monoclonal antibody for infants)—intended uptake of these products is unclear. Our objective was to evaluate intended uptake of each product and their correlates among pregnant individuals. Methods: We conducted a nationally representative survey of pregnant individuals weighted to the US population of births between September 20 and October 3, 2023. Primary outcomes included whether each participant intended to receive RSVpreF vaccine during pregnancy or immunize their infant with nirsevimab; beliefs about product safety, effectiveness and importance; and reasons for hesitancy. We used logistic regression to identify correlates of intent and product support, controlling for sociodemographic characteristics, political orientation and psychological dispositions. Results: Nearly 45% of participants intended to receive RSVpreF vaccine during their pregnancy, and 51% of participants intended to give their infants nirsevimab; 41% did not intend to use either product. Intention to use RSVpreF vaccine or nirsevimab was higher among those who were previously aware of the products and who viewed each product as safe, effective and important. Common reasons for hesitancy included concerns about side effects, impacts on infants and the immunizations being too new. Conclusions: Health communication interventions that increase awareness about RSV immunizations and highlight their safety, effectiveness and importance are needed to increase intended uptake.
- 3 June 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (11) , 1126-1133
Intention to Use RSVpreF Vaccine or Nirsevimab to Prevent Infant RSV Among Pregnant Individuals
Background: Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the United States. While 2 new immunization products have been developed to prevent RSV in infants—RSVpreF vaccine (a prefusion F protein-based vaccine for pregnant individuals) and nirsevimab (a monoclonal antibody for infants)—intended uptake of these products is unclear. Our objective was to evaluate intended uptake of each product and their correlates among pregnant individuals. Methods: We conducted a nationally representative survey of pregnant individuals weighted to the US population of births between September 20 and October 3, 2023. Primary outcomes included whether each participant intended to receive RSVpreF vaccine during pregnancy or immunize their infant with nirsevimab; beliefs about product safety, effectiveness and importance; and reasons for hesitancy. We used logistic regression to identify correlates of intent and product support, controlling for sociodemographic characteristics, political orientation and psychological dispositions. Results: Nearly 45% of participants intended to receive RSVpreF vaccine during their pregnancy, and 51% of participants intended to give their infants nirsevimab; 41% did not intend to use either product. Intention to use RSVpreF vaccine or nirsevimab was higher among those who were previously aware of the products and who viewed each product as safe, effective and important. Common reasons for hesitancy included concerns about side effects, impacts on infants and the immunizations being too new. Conclusions: Health communication interventions that increase awareness about RSV immunizations and highlight their safety, effectiveness and importance are needed to increase intended uptake.
- 11 February 2025
- Published by Elsevier in Public Health
- Vol. 241, 19-23
Identifying and mitigating the public health consequences of meta-ignorance about "Long COVID" risks
- 11 February 2025
- Published by Elsevier in Public Health
- Vol. 241, 19-23
Identifying and mitigating the public health consequences of meta-ignorance about "Long COVID" risks
- Top Cited PapersOpen Access
- 20 January 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-27
Perceptions of science, science communication, and climate change attitudes in 68 countries – the TISP dataset
Science is integral to society because it can inform individual, government, corporate, and civil society decision-making on issues such as public health, new technologies or climate change. Yet, public distrust and populist sentiment challenge the relationship between science and society. To help researchers analyse the science-society nexus across different geographical and cultural contexts, we undertook a cross-sectional population survey resulting in a dataset of 71,922 participants in 68 countries. The data were collected between November 2022 and August 2023 as part of the global Many Labs study “Trust in Science and Science-Related Populism” (TISP). The questionnaire contained comprehensive measures for individuals’ trust in scientists, science-related populist attitudes, perceptions of the role of science in society, science media use and communication behaviour, attitudes to climate change and support for environmental policies, personality traits, political and religious views and demographic characteristics. Here, we describe the dataset, survey materials and psychometric properties of key variables. We encourage researchers to use this unique dataset for global comparative analyses on public perceptions of science and its role in society and policy-making.
- 20 January 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-27
Top Cited PapersOpen AccessPerceptions of science, science communication, and climate change attitudes in 68 countries – the TISP dataset
Science is integral to society because it can inform individual, government, corporate, and civil society decision-making on issues such as public health, new technologies or climate change. Yet, public distrust and populist sentiment challenge the relationship between science and society. To help researchers analyse the science-society nexus across different geographical and cultural contexts, we undertook a cross-sectional population survey resulting in a dataset of 71,922 participants in 68 countries. The data were collected between November 2022 and August 2023 as part of the global Many Labs study “Trust in Science and Science-Related Populism” (TISP). The questionnaire contained comprehensive measures for individuals’ trust in scientists, science-related populist attitudes, perceptions of the role of science in society, science media use and communication behaviour, attitudes to climate change and support for environmental policies, personality traits, political and religious views and demographic characteristics. Here, we describe the dataset, survey materials and psychometric properties of key variables. We encourage researchers to use this unique dataset for global comparative analyses on public perceptions of science and its role in society and policy-making.